161 related articles for article (PubMed ID: 2331050)
1. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
Howat AJ; Wright AL; Cotton DW; Reeve S
Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
Evans AT; Orrell JM; Grant A
J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
Orrell JM; Evans AT; Grant A
J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
Di Gregorio C; Losi L; Annessi G; Botticelli A
Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
[TBL] [Abstract][Full Text] [Related]
6. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
Naik R; Raghuveer CV; Jacob DL
J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
[TBL] [Abstract][Full Text] [Related]
8. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
Qiu BS; Xu LZ; Kong JC; Chen HL; Tao LD
Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
[TBL] [Abstract][Full Text] [Related]
11. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative analysis of nucleolar organizer regions in nevi and melanomas].
Dujela N
Lijec Vjesn; 1993; 115(7-8):241-3. PubMed ID: 8139368
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
Howat AJ; Giri DD; Cotton DW; Slater DN
Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
[TBL] [Abstract][Full Text] [Related]
14. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
Gonzalez AP; Kumar D; Sánchez RL
Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
Deuble K; McCartney A
Eye (Lond); 1990; 4 ( Pt 5)():743-50. PubMed ID: 1704315
[TBL] [Abstract][Full Text] [Related]
16. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma.
Howat AJ; Giri DD; Wright AL; Underwood JC
J Pathol; 1988 Nov; 156(3):227-32. PubMed ID: 3204453
[TBL] [Abstract][Full Text] [Related]
17. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
Rebora A
Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar organizer regions in superficial spreading melanoma with nodule.
Albrecht S; Jambrosic JA; Kahn HJ
Mod Pathol; 1989 Nov; 2(6):666-70. PubMed ID: 2587571
[TBL] [Abstract][Full Text] [Related]
19. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
Fogt F; Vortmeyer AO; Tahan SR
Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]